V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 240014056 | 240012294 | 1.55 | 70.1 | Curative (C) | 2015-07-22 | 2015-08-10 | CARBOPLATIN + ETOPOSIDE | 2 | N | 240032382 | BEAM |
| 240014057 | 240008017 | 1.6 | 75.8 | null | 2018-09-27 | 2018-10-23 | Cisplatin + Etoposide po&iv 3 day | N | N | 240032399 | CYCLOPHOSPHAMIDE + RITUXIMAB |
| 240014058 | 240008019 | 1.7 | null | null | 2016-08-30 | 2016-09-02 | Cyclophosphamide High Dose | N | N | 240032409 | LEAM |
| 240014059 | 240008021 | 1.75 | 44.5 | Curative (C) | null | 2018-12-23 | Cyclophosphamide High Dose | N | N | 240032418 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 240014060 | 240008022 | 0 | null | null | 2016-08-16 | 2016-09-13 | Hydroxycarbamide | 02 | N | 240032439 | LEAM |
| 240014061 | 240008022 | 1.74 | 111.3 | Disease modification (D) | 2014-01-19 | 2014-01-19 | Bendamustine +/- Prednisolone | N | N | 240032439 | LENALIDOMIDE |
| 240014062 | 240008025 | null | null | Adjuvant (A) | 2014-08-12 | 2014-08-12 | Methotrexate High Dose (3g/m2) | N | null | 240032454 | LENALIDOMIDE |
| 240014063 | 240015328 | 1.58 | null | Disease modification (D) | 2013-10-10 | 2013-10-19 | Cisplatin + Topotecan | 02 | N | 240032459 | LEAM |
| 240014064 | 240015328 | null | 52 | Curative (C) | 2016-02-03 | 2016-02-04 | Hydroxycarbamide | 02 | N | 240032459 | TRASTUZUMAB |
| 240014065 | 240008026 | 1.63 | 53.2 | Disease modification (D) | 2014-01-28 | 2014-01-28 | CARBOPLATIN + GEMCITABINE | 02 | N | 240032483 | FCR |
| 240014066 | 240008030 | 1.71 | 49 | Disease modification (D) | 2014-10-18 | 2014-12-21 | Bendamustine +/- Prednisolone | N | N | 240032487 | CARBOPLATIN + ETOPOSIDE |
| 240014067 | 240008033 | 0 | null | Disease modification (D) | 2015-02-17 | 2015-12-31 | Methotrexate High Dose (3g/m2) | N | N | 240032510 | DA |
| 240014068 | 240008034 | 1.64 | 74.7 | Adjuvant (A) | 2013-01-31 | 2013-08-22 | DHAP | N | N | 240032520 | METHOTREXATE HIGH DOSE |
| 240014069 | 240008035 | 1.77 | 80.4 | Palliative (P) | 2017-09-18 | 2018-01-09 | Carboplatin + Etoposide IV 3 day | 2 | N | 240032522 | BORTEZOMIB |
| 240014070 | 240008038 | 1.52 | null | Disease modification (D) | 2016-07-20 | 2016-07-22 | FCR Oral - Cycle 2 onwards | N | N | 240032533 | CYCLOPHOSPHAMIDE + RITUXIMAB |
| 240014071 | 240014314 | 1.56 | null | Curative (C) | 2014-03-30 | 2014-03-30 | Cyclophosphamide High Dose | 02 | N | 240032542 | TRASTUZUMAB |
| 240014072 | 240012306 | 1.6 | 47.9 | Adjuvant (A) | 2017-10-22 | 2017-11-06 | Bendamustine +/- Prednisolone | 2 | N | 240032561 | DA |
| 240014073 | 240012306 | 1.69 | 64 | Disease modification (D) | 2015-12-25 | 2015-12-25 | Trastuzumab Subcutaneous | N | N | 240032561 | LENALIDOMIDE |
| 240014074 | 240008043 | 1.57 | 66 | Neo-adjuvant (N) | null | 2015-03-24 | Methotrexate High Dose (3g/m2) | N | null | 240032572 | BENDAMUSTINE |
| 240014075 | 240008046 | 1.63 | 48.4 | Curative (C) | 2014-09-24 | 2014-09-25 | Bendamustine +/- Prednisolone | 02 | N | 240032578 | CISPLATIN + ETOPOSIDE |
| 240014076 | 240012307 | null | null | Disease modification (D) | 2015-09-03 | 2015-10-01 | Hydroxycarbamide | N | N | 240032580 | HYDROXYCARBAMIDE |
| 240014077 | 240008049 | null | 81 | Disease modification (D) | 2012-09-09 | 2013-06-29 | CYCLOPHOSPHAMIDE + RITUXIMAB + Dexamethasone | 2 | null | 240032590 | ABVD |
| 240014079 | 240008052 | null | 55.2 | Curative (C) | 2018-01-29 | 2018-01-29 | TRASTUZUMAB | null | N | 240032600 | DA |
| 240014080 | 240012314 | 1.65 | 55.8 | Disease modification (D) | 2013-08-15 | 2013-08-15 | Bortezomib +/- Dexamethasone | N | N | 240032600 | METHOTREXATE HIGH DOSE |
| 240014081 | 240008056 | null | 78.3 | Curative (C) | 2016-02-17 | 2016-02-17 | FLAG + Idarubicin | N | N | 240032633 | FCR |
| 240014082 | 240008058 | 1.66 | 72 | Adjuvant (A) | 2015-02-14 | 2015-08-27 | Brentuximab | 99 | null | 240032648 | BRENTUXIMAB |
| 240014083 | 240008060 | 1.68 | 55.6 | Palliative (P) | 2017-06-04 | 2017-06-05 | IBRUTINIB | 02 | N | 240032650 | ABVD |
| 240014084 | 240008063 | 1.58 | 68 | null | 2018-04-08 | 2018-07-01 | Methotrexate High Dose (3g/m2) | 02 | N | 240032656 | GEMCITABINE |
| 240014085 | 240012320 | 1.63 | 63 | Curative (C) | 2016-08-09 | 2016-09-06 | Cisplatin + Topotecan | N | null | 240032660 | FCR |
| 240014086 | 240012320 | 1.74 | 66.1 | Palliative (P) | 2014-03-26 | 2014-07-30 | Brentuximab | 1 | null | 240032660 | BRENTUXIMAB |
| 240014087 | 240012320 | 1.63 | 58 | Palliative (P) | 2017-01-12 | 2017-01-21 | CYCLOPHOSPHAMIDE | 02 | N | 240032660 | IBRUTINIB |
| 240014088 | 240008066 | 1.67 | 55.8 | Disease modification (D) | 2017-08-14 | 2018-01-19 | Brentuximab | 02 | null | 240032690 | BRENTUXIMAB |
| 240014089 | 240014325 | null | null | Adjuvant (A) | 2018-01-20 | 2018-07-19 | Bortezomib +/- Dexamethasone | N | null | 240032716 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 240014090 | 240008070 | 0 | 70 | null | 2017-09-21 | 2017-09-21 | Bortezomib +/- Dexamethasone | 2 | N | 240032736 | METHOTREXATE |
| 240014091 | 240008071 | 1.78 | 78 | Curative (C) | 2018-03-08 | 2018-03-14 | Gemcitabine 1000mg/m2 D1 8 15 | null | null | 240032757 | CYTARABINE |
| 240014092 | 240008072 | null | 68.3 | null | 2017-10-15 | 2018-07-01 | Cyclophosphamide oral | N | null | 240032768 | LEAM |
| 240014093 | 240008074 | 1.63 | 59.5 | Palliative (P) | 2014-02-15 | 2014-02-15 | CYCLOPHOSPHAMIDE | N | null | 240032772 | CISPLATIN + TOPOTECAN |
| 240014094 | 240008075 | 1.5 | 56.5 | Not known (9) | 2017-06-16 | 2017-06-22 | Cyclophosphamide + Dex + Rituximab | 02 | N | 240032789 | CISPLATIN + TOPOTECAN |
| 240014095 | 240008077 | 1.78 | 65.3 | Curative (C) | null | 2016-09-01 | Cisplatin + Topotecan | 99 | null | 240032803 | METHOTREXATE HIGH DOSE |
| 240014096 | 240012329 | 1.68 | 84.4 | Curative (C) | 2015-01-24 | 2016-06-07 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | N | N | 240032821 | CARBOPLATIN + ETOPOSIDE |
| 240014097 | 240008081 | 1.59 | 66 | Curative (C) | 2017-12-13 | 2017-12-13 | Methotrexate High Dose (3g/m2) | N | N | 240032842 | HYDROXYCARBAMIDE |
| 240014098 | 240015854 | 1.74 | 89.6 | Curative (C) | 2016-09-10 | 2016-09-17 | Mini BEAM | null | null | 240032865 | DHAP |
| 240014099 | 240008087 | 1.8 | 69.5 | null | 2014-09-10 | 2014-09-12 | CYCLOPHOSPHAMIDE + RITUXIMAB + Dexamethasone | N | N | 240032888 | DA |
| 240014100 | 240014329 | 1.74 | 66 | Curative (C) | 2014-06-22 | 2015-12-23 | IBRUTINIB | N | N | 240032912 | IBRUTINIB |
| 240014101 | 240008093 | null | 83.5 | Adjuvant (A) | 2019-09-20 | 2019-09-21 | Hydroxycarbamide | null | null | 240032915 | R IVAC |
| 240014102 | 240008094 | 1.67 | 81.5 | Curative (C) | 2014-05-02 | 2014-08-03 | BEAM | N | N | 240032920 | METHOTREXATE |
| 240014103 | 240008095 | 1.84 | 80.5 | Curative (C) | 2017-11-18 | 2018-03-11 | Brentuximab | N | N | 240032923 | BRENTUXIMAB |
| 240014104 | 240008099 | 1.77 | 88.2 | Curative (C) | 2013-07-31 | 2013-08-02 | Carboplatin + Etoposide iv&po | N | null | 240032946 | CYTARABINE |
| 240014105 | 240008100 | 1.52 | 67.7 | null | 2017-08-06 | 2017-12-24 | BEAM | N | N | 240032953 | HYDROXYCARBAMIDE |
| 240014106 | 240008101 | null | 83.4 | Palliative (P) | 2014-12-03 | 2015-01-07 | GEMCITABINE | N | N | 240032993 | CARBOPLATIN + ETOPOSIDE |